Additionally, pathogenic alterations in PALB2 [11], ATM [12], CHEK2 [13], and NBN [14] are correlated with an increased risk for breast cancer and/or other cancers, whereas other genes such as BRIP1, RAD51C, and RAD51D are associated with an increased ovarian cancer risk [15]. This evidence concerns the gene RAD51C and ovarian carcinoma.